Trial Profile
A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with ACTH-independent Cushing's syndrome due to adrenal adenoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2014
Price :
$35
*
At a glance
- Drugs Metyrapone (Primary)
- Indications Cushing syndrome
- Focus Therapeutic Use
- 02 Jun 2014 New trial record